Literature DB >> 24577353

Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection.

Susana Fuentes1, Els van Nood2, Sebastian Tims1, Ineke Heikamp-de Jong1, Cajo J F ter Braak3, Josbert J Keller4, Erwin G Zoetendal1, Willem M de Vos5.   

Abstract

Recurrent Clostridium difficile infection (CDI) can be effectively treated by infusion of a healthy donor faeces suspension. However, it is unclear what factors determine treatment efficacy. By using a phylogenetic microarray platform, we assessed composition, diversity and dynamics of faecal microbiota before, after and during follow-up of the transplantation from a healthy donor to different patients, to elucidate the mechanism of action of faecal infusion. Global composition and network analysis of the microbiota was performed in faecal samples from nine patients with recurrent CDI. Analyses were performed before and after duodenal donor faeces infusion, and during a follow-up of 10 weeks. The microbiota data were compared with that of the healthy donors. All patients successfully recovered. Their intestinal microbiota changed from a low-diversity diseased state, dominated by Proteobacteria and Bacilli, to a more diverse ecosystem resembling that of healthy donors, dominated by Bacteroidetes and Clostridium groups, including butyrate-producing bacteria. We identified specific multi-species networks and signature microbial groups that were either depleted or restored as a result of the treatment. The changes persisted over time. Comprehensive and deep analyses of the microbiota of patients before and after treatment exposed a therapeutic reset from a diseased state towards a healthy profile. The identification of microbial groups that constitute a niche for C. difficile overgrowth, as well as those driving the reinstallation of a healthy intestinal microbiota, could contribute to the development of biomarkers predicting recurrence and treatment outcome, identifying an optimal microbiota composition that could lead to targeted treatment strategies.

Entities:  

Mesh:

Year:  2014        PMID: 24577353      PMCID: PMC4817604          DOI: 10.1038/ismej.2014.13

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  56 in total

1.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Authors:  Anne Vrieze; Els Van Nood; Frits Holleman; Jarkko Salojärvi; Ruud S Kootte; Joep F W M Bartelsman; Geesje M Dallinga-Thie; Mariette T Ackermans; Mireille J Serlie; Raish Oozeer; Muriel Derrien; Anne Druesne; Johan E T Van Hylckama Vlieg; Vincent W Bloks; Albert K Groen; Hans G H J Heilig; Erwin G Zoetendal; Erik S Stroes; Willem M de Vos; Joost B L Hoekstra; Max Nieuwdorp
Journal:  Gastroenterology       Date:  2012-06-20       Impact factor: 22.682

Review 2.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Authors:  Ethan Gough; Henna Shaikh; Amee R Manges
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

3.  Reshaping the gut microbiome with bacterial transplantation and antibiotic intake.

Authors:  Chaysavanh Manichanh; Jens Reeder; Prudence Gibert; Encarna Varela; Marta Llopis; Maria Antolin; Roderic Guigo; Rob Knight; Francisco Guarner
Journal:  Genome Res       Date:  2010-08-24       Impact factor: 9.043

Review 4.  Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.

Authors:  Thomas H Frazier; John K DiBaise; Craig J McClain
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-08-01       Impact factor: 4.016

5.  Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection.

Authors:  M J Hopkins; G T Macfarlane
Journal:  J Med Microbiol       Date:  2002-05       Impact factor: 2.472

6.  Enterotypes of the human gut microbiome.

Authors:  Manimozhiyan Arumugam; Jeroen Raes; Eric Pelletier; Denis Le Paslier; Takuji Yamada; Daniel R Mende; Gabriel R Fernandes; Julien Tap; Thomas Bruls; Jean-Michel Batto; Marcelo Bertalan; Natalia Borruel; Francesc Casellas; Leyden Fernandez; Laurent Gautier; Torben Hansen; Masahira Hattori; Tetsuya Hayashi; Michiel Kleerebezem; Ken Kurokawa; Marion Leclerc; Florence Levenez; Chaysavanh Manichanh; H Bjørn Nielsen; Trine Nielsen; Nicolas Pons; Julie Poulain; Junjie Qin; Thomas Sicheritz-Ponten; Sebastian Tims; David Torrents; Edgardo Ugarte; Erwin G Zoetendal; Jun Wang; Francisco Guarner; Oluf Pedersen; Willem M de Vos; Søren Brunak; Joel Doré; María Antolín; François Artiguenave; Hervé M Blottiere; Mathieu Almeida; Christian Brechot; Carlos Cara; Christian Chervaux; Antonella Cultrone; Christine Delorme; Gérard Denariaz; Rozenn Dervyn; Konrad U Foerstner; Carsten Friss; Maarten van de Guchte; Eric Guedon; Florence Haimet; Wolfgang Huber; Johan van Hylckama-Vlieg; Alexandre Jamet; Catherine Juste; Ghalia Kaci; Jan Knol; Omar Lakhdari; Severine Layec; Karine Le Roux; Emmanuelle Maguin; Alexandre Mérieux; Raquel Melo Minardi; Christine M'rini; Jean Muller; Raish Oozeer; Julian Parkhill; Pierre Renault; Maria Rescigno; Nicolas Sanchez; Shinichi Sunagawa; Antonio Torrejon; Keith Turner; Gaetana Vandemeulebrouck; Encarna Varela; Yohanan Winogradsky; Georg Zeller; Jean Weissenbach; S Dusko Ehrlich; Peer Bork
Journal:  Nature       Date:  2011-04-20       Impact factor: 49.962

7.  Human intestinal microbiota composition is associated with local and systemic inflammation in obesity.

Authors:  Froukje J Verdam; Susana Fuentes; Charlotte de Jonge; Erwin G Zoetendal; Runi Erbil; Jan Willem Greve; Wim A Buurman; Willem M de Vos; Sander S Rensen
Journal:  Obesity (Silver Spring)       Date:  2013-06-22       Impact factor: 5.002

8.  Treatment of ulcerative colitis using fecal bacteriotherapy.

Authors:  Thomas J Borody; Eloise F Warren; Sharyn Leis; Rosa Surace; Ori Ashman
Journal:  J Clin Gastroenterol       Date:  2003-07       Impact factor: 3.062

9.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

10.  Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

Authors:  Elaine O Petrof; Gregory B Gloor; Stephen J Vanner; Scott J Weese; David Carter; Michelle C Daigneault; Eric M Brown; Kathleen Schroeter; Emma Allen-Vercoe
Journal:  Microbiome       Date:  2013-01-09       Impact factor: 14.650

View more
  63 in total

1.  Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection.

Authors:  Alexa R Weingarden; Chi Chen; Ningning Zhang; Carolyn T Graiziger; Peter I Dosa; Clifford J Steer; Megan K Shaughnessy; James R Johnson; Michael J Sadowsky; Alexander Khoruts
Journal:  J Clin Gastroenterol       Date:  2016-09       Impact factor: 3.062

Review 2.  Application of multivariate statistical techniques in microbial ecology.

Authors:  O Paliy; V Shankar
Journal:  Mol Ecol       Date:  2016-03       Impact factor: 6.185

Review 3.  The resilience of the intestinal microbiota influences health and disease.

Authors:  Felix Sommer; Jacqueline Moltzau Anderson; Richa Bharti; Jeroen Raes; Philip Rosenstiel
Journal:  Nat Rev Microbiol       Date:  2017-06-19       Impact factor: 60.633

Review 4.  The potential for emerging therapeutic options for Clostridium difficile infection.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Gut Microbes       Date:  2014

Review 5.  Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician.

Authors:  Sara Iqbal; Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2016-09

Review 6.  Understanding the mechanisms of faecal microbiota transplantation.

Authors:  Alexander Khoruts; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-22       Impact factor: 46.802

7.  Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children.

Authors:  Jing Cheng; Tamar Ringel-Kulka; Ineke Heikamp-de Jong; Yehuda Ringel; Ian Carroll; Willem M de Vos; Jarkko Salojärvi; Reetta Satokari
Journal:  ISME J       Date:  2015-10-02       Impact factor: 10.302

Review 8.  To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes.

Authors:  Jens Walter; María X Maldonado-Gómez; Inés Martínez
Journal:  Curr Opin Biotechnol       Date:  2017-09-13       Impact factor: 9.740

9.  Dynamics of an experimental microbial invasion.

Authors:  Francisco Acosta; Richard M Zamor; Fares Z Najar; Bruce A Roe; K David Hambright
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 10.  Clostridium difficile and the microbiota.

Authors:  Anna M Seekatz; Vincent B Young
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.